The physiology of cardiovascular disease and innovative liposomal platforms for therapy

Guillermo U. Ruiz-Esparza, Jose H. Flores-Arredondo, Victor Segura-Ibarra, Guillermo Torre-Amione, Mauro Ferrari, Elvin Blanco, Rita E. Serda

Research output: Contribution to journalReview articlepeer-review

43 Scopus citations


Heart disease remains the major cause of death in males and females, emphasizing the need for novel strategies to improve patient treatment and survival. A therapeutic approach, still in its infancy, is the development of site-specific drug-delivery systems. Nanoparticle-based delivery systems, such as liposomes, have evolved into robust platforms for site-specific delivery of therapeutics. In this review, the clinical impact of cardiovascular disease and the pathophysiology of different subsets of the disease are described. Potential pathological targets for therapy are introduced, and promising advances in nanotherapeutic cardiovascular applications involving liposomal platforms are presented.

Original languageEnglish (US)
Pages (from-to)629-640
Number of pages12
JournalInternational Journal of Nanomedicine
StatePublished - Feb 7 2013


  • Cardiovascular disease
  • Liposomes
  • Nanomedicine
  • Nanoparticles
  • Therapeutics

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Organic Chemistry
  • Drug Discovery


Dive into the research topics of 'The physiology of cardiovascular disease and innovative liposomal platforms for therapy'. Together they form a unique fingerprint.

Cite this